A bill to establish a national center for clinical pharmacology in the Department of Health and Human Services.
Latest action. Referred to House Committee on Interstate and Foreign Commerce.
Establishes within the Department of Health and Human Services the National Center for Clinical Pharmacology under a Director appointed by the Secretary. Authorizes the Center to conduct and support research in clinical pharmacology and clinical pharmacy. Requires the Center to conduct an ongoing review and analysis of the use of drug products in the United States. Requires the Center to prepare an annual Drug Experience Assessment Report for the Secretary. Directs the Center to facilitate analysis of the consequences of State and Federal regulation of the manufacture, importation, exportation, and distribution of drug products, research activities and practices, and the practices of the pharmaceutical industry and health professionals respecting drug products. Requires the Director to periodically report to the Secretary on new techniques in research, areas where current research is insufficient, and promising new drugs in foreign countries.
Written by analysts at the Congressional Research Service and published on Congress.gov, not by Civibrief. Summarized at the "Introduced in House" stage on June 18, 1980. It describes the bill, it is not the legal text.
Where is it in the process, and what happens next?
4 steps remain before this bill could become law.
The record's latest action, on June 18, 1980: Referred to House Committee on Interstate and Foreign Commerce.
- Clearing the committees it was referred to, and being scheduled for a floor vote
- Passage by the House
- Passage by the Senate
- The President's signature. If the President vetoes it, two-thirds of both chambers must vote to override.
How likely is it to become law?
Civibrief does not forecast outcomes and this page has no opinion about this one. What the record supports is a base rate, which is a fact about the whole pile, not a prediction about this measure.
In the 96th Congress (1979-80), 613 of the 12,581 bills and joint resolutions introduced became law, about 4.9 percent. That count covers every measure at every stage, including the many that never left committee.
This one is not there yet: 4 steps are still outstanding, listed above.
Has anyone actually voted on it?
No. No roll call in this Congress cites this measure. That is the ordinary outcome: most measures never reach a recorded floor vote, and a committee ends most of them simply by not acting.
A vote is not the only thing that happens to a measure. Hearings, markups, and referrals are all recorded actions, and none of them is a vote of the full chamber.
Who is behind it?
CLAUDE PEPPER (D-FL) introduced it on June 18, 1980. No cosponsors are recorded.
Cosponsoring is a formal signature on the text. It is not a commitment to vote for the measure, it does not bind anyone's party, and a long list of cosponsors is a measure of attention rather than of prospects.
How long has it been in play?
It was introduced on June 18, 1980, 16885 days ago. The most recent recorded action was 16885 days ago, on June 18, 1980.
Measures do not carry over. Anything the 96th Congress has not finished by January 3, 1981 dies when the term ends, and has to be introduced again from the start in the next Congress.
Every answer above is assembled from this measure's own record on Congress.gov and from published counts of what Congress has passed before. Civibrief does not predict outcomes and takes no position on any measure.
Vote history
- HouseIn committee, no floor vote yet
- SenateAwaits House passage
- PresidentAwaits both chambers